全部照片(1)
About This Item
經驗公式（希爾表示法）:
C32H32O15
CAS號碼:
分子量：:
656.59
MDL號碼:
分類程式碼代碼:
12352201
PubChem物質ID:
NACRES:
NC.07
推薦產品
化驗
≥98% (HPLC)
形狀
powder
溶解度
methanol: 20 mg/mL, clear, yellow
儲存溫度
−20°C
SMILES 字串
OC[C@H]1O[C@@H](Oc2ccc3c(Oc4cc(O[C@@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5O)ccc4C36OC(=O)c7ccccc67)c2)[C@H](O)[C@@H](O)[C@H]1O
InChI
1S/C32H32O15/c33-11-21-23(35)25(37)27(39)30(45-21)42-13-5-7-17-19(9-13)44-20-10-14(43-31-28(40)26(38)24(36)22(12-34)46-31)6-8-18(20)32(17)16-4-2-1-3-15(16)29(41)47-32/h1-10,21-28,30-31,33-40H,11-12H2/t21-,22-,23+,24+,25+,26+,27-,28-,30-,31-/m1/s1
InChI 密鑰
ZTOBILYWTYHOJB-WBCGDKOGSA-N
尋找類似的產品？ 前往 產品比較指南
相關類別
應用
荧光素二(β-D-吡喃半乳糖苷)已用作β-半乳糖苷酶试验中的底物。
荧光素二(β-D-吡喃半乳糖苷)（FDG）已可用于通过FACS（荧光激活细胞分选）检测基因表达。
生化／生理作用
荧光素二(β-D-吡喃半乳糖苷)(FDG被β-半乳糖苷酶水解成荧光素后发出荧光。它能产生与酶活性成比例的荧光。当使用β-半乳糖苷酶（Lac Z）作为报告基因时，该分子主要用于检测转染细胞中的基因表达。
基底
β-半乳糖苷酶的荧光底物
相關產品
產品號碼
描述
訂價
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
個人防護裝備
Eyeshields, Gloves, type N95 (US)
客戶也查看了
Wei-Heong Tan et al.
Lab on a chip, 6(6), 757-763 (2006-06-02)
This paper describes an electrofusion device for controlling the precise moment of fusion between droplets by applying an electric field. This device allows (i) accurate determination of the start of chemical/biological reactions, (ii) minimum contact of reactants with channel walls--eliminating
Michael Peter Jones et al.
Radiation oncology (London, England), 14(1), 140-140 (2019-08-08)
To investigate the prognostic significance of positron emission tomography (PET) parameters from F-18 fluorodeoxyglucose (FDG) PET scans performed pre- and post- chemo-radiotherapy (CRT) for squamous cell carcinoma of the anal canal (AC). From January 2013 to January 2017, 19 patients
Serge A Mitelman et al.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 21(5), 368-382 (2019-09-26)
Objectives: Overlapping decreases in extrastriatal dopamine D2/D3-receptor availability and glucose metabolism have been reported in subjects with schizophrenia. It remains unknown whether these findings are physiologically related or coincidental.Methods: To ascertain this, we used two consecutive 18F-fluorodeoxyglucose and 18F-fallypride positron
Jose M Anton-Rodriguez et al.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 40(6), 826-835 (2019-04-30)
To investigate whether [F]fluorothymidine (FLT) and/or [F]fluorodeoxyglucose (FDG) positron emission tomography (PET) can differentiate growth in neurofibromatosis 2 (NF2) related vestibular schwannomas (VS) and to evaluate the importance of PET scanner spatial resolution on measured tumor uptake. Six NF2 patients
Shotaro Naganawa et al.
Medicine, 96(46), e8832-e8832 (2017-11-18)
Although delayed-time-point imaging is expected to improve the results of [F]-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT), how examinees will benefit from dual-time-point imaging versus initial-time-point imaging alone, remains unclear. This study investigated the role of delayed-time-point imaging in improving the
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務